SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach

被引:4
|
作者
Layer, Emily [1 ,2 ]
Hoehl, Sebastian [1 ]
Widera, Marek [1 ]
Bojkova, Denisa [1 ]
Westphal, Tim [2 ]
Gottschalk, Rene [2 ]
Boeddinghaus, Boris [2 ]
Schork, Joscha [2 ]
Ciesek, Sandra [1 ,3 ]
Goetsch, Udo [2 ]
机构
[1] Goethe Univ, Univ Hosp Frankfurt, Inst Med Virol, Frankfurt, Germany
[2] Hlth Protect Author, Frankfurt, Germany
[3] DZIF, German Ctr Infect Res, External Partner Site Frankfurt, Frankfurt, Germany
关键词
Travel regulations; SARS-CoV-2; testing; Antigen test; Quarantine;
D O I
10.1016/j.ijid.2022.02.045
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: International travel poses the risk of importing SARS-CoV-2 infections and introducing new viral variants into the country of destination. Established measures include mandatory quarantine with the opportunity to abbreviate it with a negative rapid antigen test (RAT). Methods: A total of 1,488 returnees were tested for SARS-CoV-2 with both PCR and RAT no earlier than 5 days after arrival. We assessed the sensitivity and specificity of the RAT. Positive samples were evaluated for infectivity in vitro in a cell culture outgrowth assay. We tracked if participants who tested negative were reported positive within 2 weeks of the initial test. Results: Potential infectiousness was determined based on symptom onset analysis, resulting in a sensitivity of the antigen test of 89% in terms of infectivity. The specificity was 100%. All positive outgrowth assays were preceded by a positive RAT, indicating that all participants with proven in vitro infectivity were correctly identified. None of the negative participants tested positive during the follow-up. Conclusions: RAT no earlier than the 5th day after arrival was a reliable method for detecting infectious travellers and can be recommended as an appropriate method for managing SARS-CoV-2 travel restrictions. Compliance to the regulations and a high standard of test quality must be ensured. (C) 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:126 / 131
页数:6
相关论文
共 50 条
  • [31] Evaluation of the test accuracy of a SARS-CoV-2 rapid antigen test in symptomatic community dwelling individuals in the Netherlands
    Van der Moeren, Nathalie
    Zwart, Vivian F.
    Lodder, Esther B.
    Van den Bijllaardt, Wouter
    Van Esch, Harald R. J. M.
    Stohr, Joep J. J. M.
    Pot, Joost
    Welschen, Ineke
    Van Mechelen, Petra M. F.
    Pas, Suzan D.
    Kluytmans, Jan A. J. W.
    PLOS ONE, 2021, 16 (05):
  • [32] SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project
    Schwartz, Kevin L.
    Bogoch, Isaac I.
    MacInTosh, Dwayne
    Barrow, Jeffrey
    Sindrey, Dennis
    Jha, Prabhat
    Brown, Kevin A.
    Maxwell, Brittany
    Hammond, Kath
    Greenberg, Michael
    Wasser, Eddie
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2022, 113 (06): : 898 - 903
  • [33] SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project
    Kevin L. Schwartz
    Isaac I. Bogoch
    Dwayne MacInTosh
    Jeffrey Barrow
    Dennis Sindrey
    Prabhat Jha
    Kevin A. Brown
    Brittany Maxwell
    Kath Hammond
    Michael Greenberg
    Eddie Wasser
    Canadian Journal of Public Health, 2022, 113 : 898 - 903
  • [34] Evaluation of a high volume antigen test for detection of SARS-CoV-2
    Levett, Paul N.
    Cheung, Branco
    Kustra, Jesse
    Pidduck, Tamara
    Mak, Annie
    Tsang, Frankie
    Petric, Martin
    Krajden, Mel
    JOURNAL OF CLINICAL VIROLOGY, 2021, 142
  • [35] Evaluation of automated antigen detection test for detection of SARS-CoV-2
    Mak, Gannon C. K.
    Lau, Stephen S. Y.
    Wong, Kitty K. Y.
    Chow, Nancy L. S.
    Lau, C. S.
    Ng, Ken H. L.
    Lam, Edman T. K.
    Chan, Rickjason C. W.
    Tsang, Dominic N. C.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 101 (04)
  • [36] Evaluation of false positives in the SARS-CoV-2 quantitative antigen test
    Kobayashi, Ryo
    Murai, Ryosei
    Moriai, Mikako
    Nirasawa, Shinya
    Yonezawa, Hitoshi
    Kondoh, Takashi
    Saeki, Masachika
    Yakuwa, Yuki
    Sato, Yuki
    Katayama, Yuki
    Nakafuri, Hirotaka
    Kitayama, Ikumi
    Asanuma, Koichi
    Fujiya, Yoshihiro
    Takahashi, Satoshi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (10) : 1477 - 1481
  • [37] A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings
    Erica Frew
    Douglas Roberts
    Shelly Barry
    Matthew Holden
    Amanda Restell Mand
    Emily Mitsock
    Enqing Tan
    Wei Yu
    Johan Skog
    Scientific Reports, 11
  • [38] Clinical validation of automated and rapid mariPOC SARS-CoV-2 antigen test
    Juha M. Koskinen
    Petri Antikainen
    Kristina Hotakainen
    Anu Haveri
    Niina Ikonen
    Carita Savolainen-Kopra
    Kati Sundström
    Janne O. Koskinen
    Scientific Reports, 11
  • [39] Clinical validation of automated and rapid mariPOC SARS-CoV-2 antigen test
    Koskinen, Juha M.
    Antikainen, Petri
    Hotakainen, Kristina
    Haveri, Anu
    Ikonen, Niina
    Savolainen-Kopra, Carita
    Sundstrom, Kati
    Koskinen, Janne O.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [40] A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings
    Frew, Erica
    Roberts, Douglas
    Barry, Shelly
    Holden, Matthew
    Mand, Amanda Restell
    Mitsock, Emily
    Tan, Enqing
    Yu, Wei
    Skog, Johan
    SCIENTIFIC REPORTS, 2021, 11 (01)